Patent details

EP3518932 Title: TREATMENT OF PROSTATE CANCER

Basic Information

Publication number:
EP3518932
PCT Application Number:
EP2017074849
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP178230173
PCT Publication Number:
WO2018060463
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF PROSTATE CANCER
French Title of Invention:
TRAITEMENT DU CANCER DE LA PROSTATE
German Title of Invention:
PROSTATAKREBSBEHANDLUNG
SPC Number:

Dates

Filing date:
29/09/2017
Grant date:
13/11/2024
EP Publication Date:
07/08/2019
PCT Publication Date:
05/04/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/11/2024
EP B1 Publication Date:
13/11/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/09/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/11/2024
 
 

Name:
Sumitomo Pharma Switzerland GmbH
Address:
Aeschengraben 27 Floor 22, 4051 Basel, Switzerland (CH)

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, Japan (JP)

Inventor

1

Name:
MACLEAN, David B.
Address:
United States (US)

2

Name:
FAESSEL, Hélène M.
Address:
United States (US)

3

Name:
MUDD, Paul, N.
Address:
United States (US)

4

Name:
RAJASEKHAR, Vijaykumar Reddy
Address:
United States (US)

5

Name:
JOHNSON, Brendan Mark
Address:
United States (US)

6

Name:
SEELY, Lynn
Address:
United States (US)

Priority

1

Priority Number:
201662402004 P
Priority Date:
30/09/2016
Priority Country:
United States (US)

2

Priority Number:
201662402150 P
Priority Date:
30/09/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/513; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202446
Publication date:
13/11/2024
Description:
Grant (B1)

2

Issue number:
202451
Publication date:
18/12/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/09/2025
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages